Vertex Pharmaceuticals Incorporated (LON: 0QZU)
London
· Delayed Price · Currency is GBP · Price in USD
430.01
+1.23 (0.29%)
At close: Jan 22, 2025
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 5,400 employees as of December 31, 2023. The number of employees increased by 600 or 12.50% compared to the previous year.
Employees
5,400
Change (1Y)
600
Growth (1Y)
12.50%
Revenue / Employee
1.47M GBP
Profits / Employee
-66.29K GBP
Market Cap
89.50B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Vertex Pharmaceuticals News
- 9 days ago - Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript) - Seeking Alpha
- 10 days ago - Lost Money on Vertex Pharmaceuticals Incorporated(VRTX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - Accesswire
- 10 days ago - Vertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025 - GuruFocus
- 10 days ago - Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - Business Wire
- 13 days ago - Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure - Benzinga
- 13 days ago - Zai Lab Ltd (ZLAB) Partners with Vertex Pharmaceuticals for Povetacicept Development in Asia - GuruFocus
- 13 days ago - Vertex Pharmaceuticals and Zai Lab Announce Strategic Collaboration for Povetacicept in Asia - GuruFocus
- 13 days ago - Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire